US government drops $200M into South African manufacturing operation for Covid-19 vaccines
Late in the Covid-19 pandemic, a spotlight has been cast on Africa as the continent has lagged behind on vaccine rollouts. Now, looking to make a difference, the US will drop a major investment in South African manufacturer Aspen Pharmaceutical to keep up with demand.
The US government will dole out $200 million to Aspen’s Gqeberha plant to expand J&J vaccine production, News24 in South Africa has reported. US Consul-General Will Stevens announced the investment in an email to Eastern Cape government and Eastern Cape Premier Oscar Mabuyane confirmed it in a press briefing, News24 reports.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.